Physician Burnout, Selpercatinib Approval, COVID-19 NewsMay 18, 2020 | Oncology All Specialties 2024’s Most and Least Burned Out Physicians By Specialty Emergency medicine tops the burnout list again in 2024, with 63% of physicians reporting burnout, while plastic surgery reports the lowest at 37%. Read full article Hematology FDA Approves Selpercatinib as First Therapy for Certain Patients With Lung, Thyroid Cancers Based on the results of an open-label trial, selpercatinib (Retevmo) becomes the first targeted therapy to be granted accelerated approval by the FDA for use in patients with cancer who have certain tumors that have an alteration (mutation or fusion) in the RET gene. Read full article